Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determinants and Consequences of the Transition to Adulthood for Adolescents With Severe Haemophilia: TRANSHEMO 2, an Ancillary Study to the TRANSHEMO Project

NCT07418827 is registered in ClinicalTrials.gov with Assistance Publique Hopitaux De Marseille as lead sponsor.

NCT NCT07418827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07418827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determinants and Consequences of the Transition to Adulthood for Adolescents With Severe Haemophilia: TRANSHEMO 2, an Ancillary Study to the TRANSHEMO Project
Lead sponsor
Assistance Publique Hopitaux De Marseille
Phase
Observational
Overall status
Recruiting
Start date
May 28, 2026
Completion date
June 30, 2027
Enrollment
75 (estimated)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

haemophilia